A perineurioma is a rare, almost always benign tumor that grows from perineurial cells, the specialized cells that form the protective sheath around bundles of nerve fibers. Because these tumors come in several forms and can mimic other nerve conditions, they are frequently misdiagnosed or recognized only after years of slowly worsening symptoms. The good news is that most perineuriomas grow slowly, stay confined to their original location, and carry low overall risk, but the treatment decisions around them are surprisingly complex.
Where Perineuriomas Come From
Every peripheral nerve in your body is wrapped in layers of tissue, much like insulation around electrical wiring. The outermost protective layer, called the perineurium, is made up of perineurial cells. These cells share some molecular features with the lining cells of the brain and spinal cord, and they test positive for a protein marker called epithelial membrane antigen (EMA), a finding that helps pathologists distinguish perineuriomas from other nerve tumors under the microscope.1PubMed. Immunohistochemical detection of epithelial membrane antigen in normal perineurial cells and perineurioma When perineurial cells begin to multiply abnormally, the result is a perineurioma. Unlike schwannomas and neurofibromas, which arise from different cell types within the same nerve environment, perineuriomas are composed exclusively of perineurial cells.
The Main Types
Perineuriomas are not one uniform tumor. They are classified into several variants depending on where and how they grow, and the distinction matters because the symptoms, the typical patient, and the treatment approach differ considerably between them.2PubMed Central. Sclerosing perineurioma of the anterior chest wall in an active Caucasian toddler: a case report
- Intraneural perineurioma: Grows within a nerve itself, gradually expanding and thickening the nerve from the inside. This is the type most associated with neurological symptoms like weakness and numbness.
- Soft tissue (conventional) perineurioma: Develops outside of a nerve, typically in the skin or the tissue just beneath it. It usually shows up as a painless lump.
- Sclerosing perineurioma: A variant of the soft tissue type characterized by dense, fibrous tissue. These tend to appear on the fingers or hands of younger patients.
- Reticular perineurioma: The rarest variant, with a distinctive lace-like microscopic pattern.3PubMed. Ultrasound and MR findings in sclerosing perineurioma
All four types are classified as benign, and they do not typically spread to other parts of the body. However, the intraneural type can cause real functional problems because of its location inside a working nerve.
Symptoms of Intraneural Perineurioma
Intraneural perineuriomas tend to show up in young people. One large longitudinal study reported a median age of symptom onset around 14 years, though cases have been documented in patients from infancy through the mid-fifties.4Brain. Longitudinal study of intraneural perineurioma—a benign, focal hypertrophic neuropathy of youth The sciatic nerve and its branches are the most commonly affected, though these tumors can involve virtually any peripheral nerve.5PubMed. Intraneural perineuriomas: diagnostic value of magnetic resonance neurography
The hallmark is a gradual, painless loss of motor function. You might notice that a foot starts to drop, a hand grip weakens, or certain movements become difficult without any obvious injury. Because the weakness comes on slowly and there is little or no pain, patients and even clinicians sometimes chalk it up to other causes for months or years before the tumor is identified. While motor deficits dominate the picture, mild sensory symptoms are not uncommon. In the same longitudinal study, about half of the patients experienced some degree of tingling, “asleep numbness,” or mild pain, and a number had measurable sensory loss on examination.4Brain. Longitudinal study of intraneural perineurioma—a benign, focal hypertrophic neuropathy of youth
The condition is usually a mononeuropathy, meaning it affects a single nerve, though in some cases it can involve a nerve plexus. An important reassurance is that intraneural perineuriomas tend to stay confined to their original nerve distribution; they do not jump to new nerves or metastasize.
Symptoms of Soft Tissue Perineurioma
Soft tissue perineuriomas present very differently. Rather than neurological deficits, the main finding is typically a painless, slowly growing mass. These can appear in the skin, the tissue beneath it, or deeper soft tissues in various parts of the body.6PubMed. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features The sclerosing variant has a particular tendency to appear on the fingers and palms, where it can be mistaken for a ganglion cyst or other common hand lump.3PubMed. Ultrasound and MR findings in sclerosing perineurioma
Because soft tissue perineuriomas sit outside of nerves, they rarely cause weakness or sensory changes. The concern with these masses is usually cosmetic or diagnostic: a patient notices a lump, wonders what it is, and the real challenge is getting it correctly identified. Many soft tissue perineuriomas are discovered incidentally during imaging for something else or during surgical removal of what is assumed to be a different type of lump altogether.
How Perineuriomas Are Diagnosed
Diagnosing a perineurioma can be tricky because these tumors are uncommon enough that many clinicians have limited experience with them. The approach depends on the type suspected.
For intraneural perineuriomas, MRI is the key imaging tool. These tumors produce a characteristic pattern on MRI: a fusiform (spindle-shaped) enlargement of the affected nerve, bright signal on fluid-sensitive sequences, and uniform contrast enhancement. A set of diagnostic criteria has been proposed that, when fully met, can identify an intraneural perineurioma with enough confidence that a biopsy becomes unnecessary. The criteria include having no cancer history, a single tumor site, strong and uniform contrast enhancement on MRI, a fusiform shape, nerve enlargement, and an age of 40 years or younger.7Journal of Neurosurgery. Clinicoradiological features of intraneural perineuriomas obviate the need for tissue diagnosis When all criteria line up, clinicians can feel confident in the diagnosis without cutting into the nerve, which itself carries risk of further damage.
When the picture is ambiguous, or when a soft tissue perineurioma needs to be distinguished from other tumors, pathology comes into play. Under the microscope, perineuriomas stain positive for EMA and negative for S-100, a marker that lights up in schwannomas and neurofibromas. This staining pattern is the most reliable way to pin down the diagnosis.1PubMed. Immunohistochemical detection of epithelial membrane antigen in normal perineurial cells and perineurioma The distinction matters because schwannomas and neurofibromas can look similar on imaging but carry different treatment implications.
One wrinkle in diagnosis is the existence of hybrid tumors: growths that contain a mix of perineurioma and schwannoma cells, or perineurioma and neurofibroma cells. The most common combination is perineurioma-schwannoma, and these hybrids usually show up in the skin or just beneath it. They are generally benign, but identifying them requires careful pathology work because the mixed cell populations can be confusing.8PubMed Central. Hybrid peripheral nerve sheath tumours – A Review
Genetics Behind the Two Main Types
One of the more interesting findings in recent years is that intraneural and soft tissue perineuriomas appear to be driven by different genetic events, despite being classified under the same name.
In intraneural perineuriomas, a genomic study found that about 60% of cases carried mutations in a gene called TRAF7, specifically in a region of the gene that is also mutated in meningiomas, a type of brain tumor. This overlap hints at a shared molecular pathway between the two tumor types.9PubMed Central. Genomic Analysis Reveals Frequent TRAF7 Mutations in Intraneural Perineuriomas
Soft tissue perineuriomas tell a different story. A genomic analysis of these tumors found no TRAF7 mutations at all. Instead, the most common changes were large deletions on chromosome 22 (involving the NF2 gene) and chromosome 17 (involving the NF1 gene). These two deletion types were almost always mutually exclusive, meaning a given tumor had one or the other but rarely both. NF1 and NF2 are well-known tumor suppressor genes linked to other nerve sheath tumors like neurofibromas and schwannomas, so their involvement here suggests that soft tissue perineuriomas share some common biology with those tumors despite looking different under the microscope.10PubMed. Recurrent Genomic Alterations in Soft Tissue Perineuriomas
For patients and families, the practical takeaway is that perineuriomas are not inherited conditions in the way that neurofibromatosis is. These genetic changes occur within the tumor itself and are not typically passed from parent to child. There is no established screening protocol for family members.
Treatment Options for Intraneural Perineurioma
This is where the evidence gets genuinely complicated, and where opinions among specialists diverge. Because intraneural perineuriomas grow inside nerves that are still partially functioning, every treatment option carries trade-offs.
The main approaches include observation (watchful waiting), surgical removal of the tumor with or without nerve graft repair, nerve transfer, and tendon transfer.11PubMed Central. Treatment of childhood intraneural perineurioma: A case report and literature review Choosing among them depends on several factors: how much function the affected nerve still has, which nerve is involved, the patient’s age, and whether symptoms are stable or worsening.
Observation is a legitimate first-line strategy and is what some experts favor for the majority of cases. The longitudinal data supporting this approach is fairly reassuring. In a study that followed patients over time, the degree of neurological impairment remained relatively stable, with median disability scores indicating mild impairment that did not interfere with daily activities. Most patients described their symptoms as either unchanged or only slightly worse over the follow-up period.4Brain. Longitudinal study of intraneural perineurioma—a benign, focal hypertrophic neuropathy of youth The researchers behind that study concluded that because these tumors are static or slowly progressive and stay confined to their original nerve distribution, routine resection is probably not warranted.
When surgery is considered, the options come with caveats. Removing the tumor often means sacrificing the nerve segment it inhabits, since the tumor cells are woven into the nerve tissue and cannot be cleanly separated. A nerve graft can bridge the gap, but recovery of function through a graft is never guaranteed and can take a year or more. Nerve transfers, where a nearby less-critical nerve is rerouted to take over the function of the damaged one, are another option that avoids removing the tumor altogether.
Tendon transfers, which bypass the nerve problem entirely by rerouting a working muscle to compensate for a paralyzed one, have had mixed results. In one analysis of patients with plexal intraneural perineuriomas who underwent tendon transfer, half experienced failure over time because the disease progressed to affect the donor muscles as well.12PubMed. Plexal intraneural perineurioma: an analysis of the clinicoradiologic presentation of this rare variant This poor long-term track record makes tendon transfer a less reliable option than it might seem on paper.
Treatment of Soft Tissue Perineurioma
Soft tissue perineuriomas are much more straightforward to manage. Because they sit outside of nerves, surgical excision is usually curative. A surgeon removes the mass with a small margin of surrounding tissue, and recurrence is uncommon. These tumors do not require radiation or chemotherapy. The main challenge, as noted earlier, is getting the diagnosis right in the first place, since many soft tissue perineuriomas are initially thought to be something else. Once removed and correctly identified on pathology, most patients need nothing more than routine follow-up.
Outcomes Across All Approaches
A systematic review pooling published cases of treated perineuriomas gives a useful snapshot of what happens over time. Among patients who were tracked after treatment, neurological function stayed the same in roughly 46% of cases, improved in about 34%, and worsened in about 21%.13PubMed Central. Modern treatment of perineuriomas: a case-series and systematic review Those numbers cover a mix of surgical and non-surgical management strategies, so they represent the overall landscape rather than the outcome of any one approach.
What stands out is that for a tumor often described as benign, the rate of neurological worsening is not trivial. Some of that worsening reflects the natural slow progression of untreated intraneural tumors, while some is a consequence of surgery itself. This is exactly why the treatment debate persists: surgery can help some patients regain function, but it can also make things worse if the wrong approach is chosen or if the tumor involves a nerve segment that is too critical to sacrifice.
The Extremely Rare Malignant Counterpart
Nearly all perineuriomas are benign, but a malignant version exists. Malignant perineuriomas, sometimes classified under the broader umbrella of malignant peripheral nerve sheath tumors (MPNSTs) with perineurial features, are exceedingly uncommon. One study identified just five such cases, with tumors arising from small nerves in various locations.14PubMed. Sporadic Malignant Perineurioma: A Rare Diagnosis Among Malignant Peripheral Nerve Sheath Tumors A separate pathology study similarly found seven perineurial MPNSTs among a larger set of malignant nerve sheath tumors. These tumors ranged considerably in size and location, from the extremities to the trunk and face, and were classified as either high-grade or low-grade malignant. None of the cases in that series were associated with the hereditary condition neurofibromatosis type 1.15The American Journal of Surgical Pathology. Perineurial Malignant Peripheral Nerve Sheath Tumor (MPNST)
The rarity of malignant perineuriomas means there is no standardized treatment protocol. Surgical removal is the mainstay, often followed by radiation for high-grade tumors, but the published evidence consists of individual case reports and very small case series rather than clinical trials. If you have been diagnosed with a benign perineurioma, the chances of it transforming into a malignant tumor are vanishingly small, and this is not something most patients need to worry about.
Why Perineuriomas Are Often Misdiagnosed
Perineuriomas are under-recognized in clinical practice, and misdiagnosis is common enough that it deserves its own discussion. Intraneural perineuriomas in particular can masquerade as chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve condition treated with immunosuppressive drugs. Both conditions can cause progressive motor weakness in a limb, and both can produce nerve enlargement visible on MRI. Some patients with intraneural perineurioma receive months or years of ineffective immunotherapy before the true diagnosis is made.
The key distinguishing features are the pattern and distribution of involvement. Intraneural perineuriomas are typically focal, affecting one nerve or one segment of a plexus, while CIDP tends to be more widespread. The MRI criteria described earlier can help, and the immunostaining profile (EMA-positive, S-100-negative) on biopsy settles the question definitively.7Journal of Neurosurgery. Clinicoradiological features of intraneural perineuriomas obviate the need for tissue diagnosis The researchers who developed the imaging diagnostic criteria specifically noted that when all criteria are met, tissue biopsy can be avoided altogether, sparing the patient an invasive procedure on an already compromised nerve.
For soft tissue perineuriomas, the common misidentifications run in a different direction: dermatofibromas, fibromatosis, or low-grade fibromyxoid sarcoma. These look-alikes are sorted out on pathology rather than imaging, reinforcing why any unexplained soft tissue mass that is surgically removed should always be sent for thorough histological examination.
Living with an Intraneural Perineurioma
For the majority of people diagnosed with an intraneural perineurioma, the day-to-day reality is one of adaptation rather than crisis. Disability levels tend to be mild, with most patients able to carry out normal daily activities. Physical therapy and occupational therapy can help compensate for weakness, especially when the tumor affects nerves controlling the hand or foot. Ankle-foot orthoses, for example, are commonly prescribed for patients with peroneal nerve involvement who develop foot drop.
Periodic imaging follow-up, typically with MRI every one to two years, is standard practice for patients being managed conservatively. The goal is to confirm that the tumor is behaving as expected and not growing aggressively or extending beyond its original boundaries. Because these tumors tend to be indolent, many patients go years between meaningful changes on imaging. The emotional aspect of living with a rare tumor is worth acknowledging as well: finding specialists who actually know what a perineurioma is can itself be a challenge, and connecting with other patients through rare disease networks can help reduce the isolation that often accompanies uncommon diagnoses.